Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy

Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy have?

Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy has 18 citations in the OpenAlex counts ScholarIQ stores.

When was Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy published?

Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy has 2022 year in the ScholarIQ index.

What is the open-access status of Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy?

Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy has closed oa status in the ScholarIQ index.

What is the DOI of Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy?

The DOI for Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy is on the source record.

What is the PMID of Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy?

The PMID for Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy is on the source record.

What is the OpenAlex record for Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy?

The OpenAlex for Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy is on the source record.